FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Opmx Pentrexcilina Jarabe NF Recall

Pentrexcilina Jarabe NF (dextromethorphan HBr and guaifenesin) liquid, 118 mL/ 4 fl oz…

OPMX, LLC · San Diego, CA

Risk level
Class II
Reported by FDA
May 1, 2013
Recall ID
D-300-2013
Check your lot numberHow we source this data

Summary

Opmx recalled Pentrexcilina Jarabe NF starting Apr 12, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-300-2013 on May 1, 2013. Reason: Labeling: Not Elsewhere Classified: Pentrexcilina Tablets and Pentrexcilina Liquid are being recalled because the product labels are misleading because they may be confused with Pentrexyl, a prescription antibiotic used to treat respiratory illnesses in Mexico. Status: Terminated.

Why it was recalled

Labeling: Not Elsewhere Classified: Pentrexcilina Tablets and Pentrexcilina Liquid are being recalled because the product labels are misleading because they may be confused with Pentrexyl, a prescription antibiotic used to treat respiratory illnesses in Mexico.

Product description

Pentrexcilina Jarabe NF (dextromethorphan HBr and guaifenesin) liquid, 118 mL/ 4 fl oz bottle, Distributed by Laboratorios Nordimex Co., San Diego, CA 92154, UPC 0 91965 02001 1.

Lot numbers, UPCs & expiration codes

Lot #: 11649A0, Exp 12/13

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-300-2013
Classification
Class II
Status
Terminated
Recall initiated
Apr 12, 2013
FDA report date
May 1, 2013
Quantity
7,610 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
OPMX, LLC

Original FDA data

Every field from FDA enforcement report D-300-2013, exactly as published.

Show all FDA fields
City
San Diego
State
CA
Status
Terminated
Country
United States
Event ID
64933
Address
6225 Progressive Dr
Address (line 2)
# 200
Code information
Lot #: 11649A0, Exp 12/13
Postal code
92154-6643
Report date
May 1, 2013
Product type
Drugs
Recall number
D-300-2013
Classification
Class II
Recalling firm
OPMX, LLC
Product quantity
7,610 bottles
Termination date
Aug 22, 2013
Reason for recall
Labeling: Not Elsewhere Classified: Pentrexcilina Tablets and Pentrexcilina Liquid are being recalled because the product labels are misleading because they may be confused with Pentrexyl, a prescription antibiotic used to treat respiratory illnesses in Mexico.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Pentrexcilina Jarabe NF (dextromethorphan HBr and guaifenesin) liquid, 118 mL/ 4 fl oz bottle, Distributed by Laboratorios Nordimex Co., San Diego, CA 92154, UPC 0 91965 02001 1.
Distribution pattern
Nationwide
Recall initiation date
Apr 12, 2013
Initial firm notification
Letter
Center classification date
Apr 25, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-300-2013, published May 1, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls